-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Olin Biotech's announcement, Taichang Group, a shareholder holding more than 5% of the company's shares, holds 25.893 million shares of the company, accounting for 6.39% of the company's total share capital. Taichang Group has pledged 3.6 million shares, accounting for 13.90% of its total holdings and 0.89% of the company's total share capital. The purpose of the pledge is financing guarantee, and the pledge period is from November 5, 2026 to November 5, 2036. After the pledge was completed, Taichang Group pledged a total of 19.41 million shares of the company, accounting for 74.96% of its total shareholding and 4.79% of the company's total share capital.

Zhitongcaijing·11/16/2026 08:57:02
Listen to the news
According to Olin Biotech's announcement, Taichang Group, a shareholder holding more than 5% of the company's shares, holds 25.893 million shares of the company, accounting for 6.39% of the company's total share capital. Taichang Group has pledged 3.6 million shares, accounting for 13.90% of its total holdings and 0.89% of the company's total share capital. The purpose of the pledge is financing guarantee, and the pledge period is from November 5, 2026 to November 5, 2036. After the pledge was completed, Taichang Group pledged a total of 19.41 million shares of the company, accounting for 74.96% of its total shareholding and 4.79% of the company's total share capital.